• Non ci sono risultati.

La palliazione endoscopica con protesi delle neoplasie dell'esofago: studio comparativo

N/A
N/A
Protected

Academic year: 2021

Condividi "La palliazione endoscopica con protesi delle neoplasie dell'esofago: studio comparativo"

Copied!
7
0
0

Testo completo

(1)

BIBLIOGRAFIA

(1) Global Cancer Facts & Figures 2nd Edition. American Cancer Society, 2010 (2) Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J

Clin 2005;55:74-108.

(3) Sundelof M, Ye W, Dickman PW, et al. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 2002;99:751–4.

(4) Xinopoulos D, Dimitroulopoulos D, TsamakidisK, et al. Palliative treatment of advanced esophageal cancer with metal-covered expandable stents: a cost-effectiveness and quality of life study. J BUON 2005;10:523–528.

(5) Altekruse SF, Kosary CL, Neyman N et al. :SEER Cancer Statistic review 1975-2007. Posted by SEER website, 2010

(6) Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681-1687,2001 (7) Baron TH: A practical guide for choosing an expandable metal stent for GI

malignancies: is a stent by any other name still a stent? Gastroint Endosc 54:269-272, 2001

(8) Petruzziello L, Costamagna G. Stenting inesophageal strictures. Dig Dis 2002;20:154–166.

(9) Bethge N, et al: Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents. Am J of

(2)

(10) Ring ME: How a dentist’s name became a synonym for a life-saving device: the story of Dr. Charles Stent. J Hist Dent 49:77-80, 2001

(11) Weldon CS, Ameli MM, Morovati SS, et al: A prosthetic stented homograft for mitral valve replacement. J Surg Res 12:548-552, 1966

(12) Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681-1687,2001 (13) Ell C, May A: Self-expanding metal stents for palliation of stenosing

tumors of the distal esophagus and gastric cardia: a critical review.

Endoscopy 29:392-398, 1997

(14) Vakil N, Morris AI, Marcon N, et al: A prospective, random-ized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001;96:1791–6.

(15) May A, Hahn EG, Ell C: Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin

Gastroenterol 22:261-266, 1996

(16) Sabharwal T, Hamady MS, Chui S, et al: A randomized prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 52:922-926, 2003

(17) Parker CH, Peura DA. Palliative treatment of esophageal carcinoma using esophageal dilatation and prosthesis. Gastroenterol Clin North Am 20:717-29,

(3)

1991.

(18) Fugger R, Niederle B, Jantsch H, et al.: Endoscopic tube implantation for the palliation of malignant esophageal stenosis. Endoscopy 22:101-4, 1990 (19) Maroju NK, Anbalagan P, Kate V, Ananthakrishnan N. Improvement in

dysphagia and quality of life with self-expanding metallic stents in malignant esophageal strictures. Indian J Gastroenterol 2006;25:62–65.

(20) Kozarek RA, Ball TJ, Brandabur JJ, et al. Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 1996;43:204–208.

(21) Taal BG, Kooyman WM, Boot H. Expandable stents compared to conventional plastic endoprostheses in malignant oesophageal obstruction, especially in cardiac cancer and fistulas: the experience of the Netherlands Cancer Institute. Eur J Gastroenterol Hepatol 1998;10:745–752.

(22) Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329:1302–1307.

(23) Sanyika C, Corr P, Haffejee A. Palliative treatment of oesophageal carcinoma—efficacy of plastic versus self-expandable stents. S Afr Med 1999;89:640–643.

(24) Solito B, Repici A, Van Boeckel G.A. et al. New metal stent with a controlled-release system for pallation of malignant dysphagia: a prospective, multi center study. Gastrointest Endosc 2010, 3: 455-460.

(4)

recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 2004;36:880-6.

(26) Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.

Am J Gastroenterol 2007;102:2667-77.

(27) Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet

2004;364:1497-504.

(28) Sabharwal T, Hamady MS, Chui S, et al. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003;52:922-6.

(29) Verschuur EM, Steyerberg EW, Kuipers EJ, et al. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 2007;65:592-601.

(30) Verschuur EM, Repici A, Kuipers EJ, et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008;103:304-12.

(31) Conigliaro R, Battaglia G, Repici A, et al. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol 2007;19:195-203.

(5)

(32) Dormann AJ, Eisendrath P, Wigginghaus B, et al. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 2003;35:207-11.

(33) Szegedi L, Gal I, Kosa I, et al. Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J

Gastroenterol Hepatol 2006;18:1197-201.

(34) Verschuur EM, Homs MY, Steyerberg EW, et al. A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest Endosc 2006;63:134-40.

(35) O’Donnell CA, Fullarton GM, Watt E, et al. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 2002;89:985–92.

(36) Siersema PD, Hop WC, van Blankestein M, et al. A com- parison of 3 types of covered metal stents for the pallia- tion of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study.

Gastrointest Endosc 2001;54:145–53.

(37) Siersema PD, Hop WC, Dees J et al. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: A controlled, prospective study.

Gastrointest Endosc 1998;47:113–20.

(38) Siersema P: Treatment options for esophageal strictures. Nat Clin Pract

Gastroenterol Hepatol 5:142-152, 2008

(6)

Gastrointest Endosc Clin N Am 17:83-104, 2007

(40) Dua KS, Kozarek R, Kim J, et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 2001;53:603-13

(41) Homs MY, Wahab PJ, Kuipers EJ, et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc 2004;60:695-702.

(42) Kocher M, Dlouhy M, Neoral C, et al. Esophageal stent with antireflux valve for tumors involving the cardia: work in progress. J Vasc Interv Radiol 1998;9:1007-10.

(43) Laasch HU, Marriott A, Wilbraham L, et al. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 2002;225:359-65.

(44) Osugi H, Lee S, Higashino M, et al. Usefulness of self-expandable metallic stent with an antireflux mechanism as a palliation for malignant strictures at the gastroesophageal junction. Surg Endosc 2002;16:1478-82.

(45) Power C, Byrne PJ, Lim K, et al. Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial. Dis Esophagus 2007;20:466-70.

(46) Sabharwal T, Gulati MS, Fotiadis N, et al. Randomised comparison of the FerX Ella antireflux stent and the Ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. J Gastroenterol Hepatol

(7)

2008;23:723-8.

(47) choppmeyer K, Golsong J, Schiefke I, et al. Antireflux stents for palliation of malignant esophagocardial stenosis. Dis Esophagus 2007;20:89-93.

(48) Verschuur EM, Homs MY, Steyerberg EW, et al. A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest Endosc 2006;63:134-40.

Riferimenti

Documenti correlati

Características normais de adipócitos e componentes do estroma também foram observados nas biópsias do tecido adiposo que foram retiradas das áreas tratadas de forma simulada nos

We analysed a representative plot irrigated through a shallow well drilled in the sand dam aquifer, in terms of yield, Crop Water Productivity (CWP), Crop Water Productivity based

However, several observations suggest that in patients with MPD, the situation is more complex and that other mutations may precede the acquisition of JAK2 V617F 54–56 The

As information systems are more and more pervasive and integrated with both the physical and the social worlds, humans will have to be necessarily considered an integral specimen

The evaluation of expandable radiocollars is ongoing (e.g. Keister et al.. Figure 1 - Materials deployed to build expandable radiocollars for subadult cervids: A) Layers of

article (i.e. /is/ → [izi] ‘the’) makes it the case that the initial segment appears in intervocalic position. Thus, it seems to create the context for lenition. However,

Indications in appropriate patients for urethral stent place- ment include urethral stricture disease, benign prostatic hyperplasia (BPH), detrusor-sphincter dyssynergia (DSD),

As a result, the role of 16-slice CTA after PCI is limited to the detection of disease progression in the coronary segments without stents, detection of ste- nosis near the edges